Objectives:
1-Discuss clinical features and laboratory markers can be used to classify pediatric patients with febrile neutropenia (FN ) as being at low or high risk for poor outcomes?
2-Discuss the research question; Does depth and duration of neutropenia at presentation predict outcomes? Comparison between IDSA guidelines and my research study results
3-Discuss the research question; Prolonged vs recurrent FN; Should management differ ?
Session date:
06/19/2017 - 12:00pm to 1:00pm CDT
Location:
UCMC
C-400
Chicago, IL
60637
United States
See map: Google Maps
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Speaker Name:
Muayad Alali, MD